---

Respiratory Failure: Detailed Clinical Management

---

1. Definition and Classification

---

2. Severity Classification (COPD Model - Applicable Broadly)

• Rosen's Emergency Medicine, Box 60.1

---

3. Pathophysiology and Causes

Mechanisms of Hypoxemia (Type 1)

1. V/Q mismatch - commonest cause (pneumonia, pulmonary embolism, COPD, atelectasis)
2. Intrapulmonary shunt - blood bypasses ventilated alveoli (ARDS, hepatopulmonary syndrome, cardiac shunt)
3. Diffusion impairment - interstitial lung disease, emphysema
4. Hypoventilation - raises alveolar PCO2, reduces PAO2
5. Low inspired FiO2 - high altitude

Mechanisms of Hypercapnia (Type 2)

• Decreased respiratory muscle strength (fatigue, disuse atrophy, malnutrition, hypophosphatemia, hypokalemia)
• Decreased motor neuron function (Guillain-Barre syndrome, phrenic nerve injury, myasthenia gravis)
• Airflow limitation (bronchospasm, upper airway obstruction, secretions)
• Loss of lung volume (lung resection, large pleural effusion, tense abdomen)

• Increased dead space (V/Q mismatch, pulmonary embolism)
• Increased CO2 production (fever, sepsis, overfeeding, thyrotoxicosis)

Categories of Causes by System

---

4. Clinical Evaluation

History and Physical

• Presenting symptoms: dyspnea, orthopnea, cough, sputum, chest pain
• Onset and tempo (acute vs. chronic)
• Baseline functional status and prior pulmonary disease
• Signs: tachypnea, accessory muscle use, paradoxical breathing, cyanosis, altered mentation, diaphoresis, tripod positioning
• Dynamic hyperinflation in COPD: increased end-expiratory lung volume, alveolar overdistension, decreased compliance, elevated work of breathing, and respiratory muscle fatigue ultimately cause hypercapnia - Rosen's Emergency Medicine

Investigations

---

5. Clinical Management

Step 1: Immediate Stabilization (First Minutes)

• Position: Head of bed 30-45°, sitting up to recruit lung bases
• Airway: Assess patency; suction secretions; jaw thrust/chin lift if needed; oral/nasal airway as bridge
• Oxygen: Start supplemental oxygen immediately (see targets below)
• IV access, monitoring: SpO2, ETCO2 if available, continuous ECG, BP

Step 2: Oxygen Therapy Targets

1. Nasal cannula: 1-6 L/min → FiO2 24-44%; for mild hypoxemia
2. Simple face mask: 6-10 L/min → FiO2 35-55%
3. Non-rebreather mask (NRM): 10-15 L/min → FiO2 60-90%
4. High-Flow Nasal Cannula (HFNC): Up to 60 L/min, FiO2 up to 100% - see below
5. NIV (BiPAP/CPAP) - see below
6. Invasive mechanical ventilation - when above measures fail

Step 3: High-Flow Nasal Cannula (HFNC)

• Delivers heated, humidified gas at high flows (up to 60 L/min)
• Provides a small degree of PEEP (~0.5-1 cmH2O/10 L/min of flow)
• Washes nasopharyngeal dead space (reduces CO2 rebreathing)
• Reduces work of breathing
• Better tolerated than NIV face mask

Step 4: Non-Invasive Ventilation (NIV)

• COPD exacerbation with hypercapnia (pH <7.35, PaCO2 >45 mmHg) - reduces intubation rate, ICU mortality, and length of stay
• Acute cardiogenic pulmonary edema - CPAP reduces need for intubation
• Immunocompromised patients with acute hypoxemic RF (avoids complications of intubation)
• Neuromuscular disease with respiratory failure (BiPAP)
• Post-extubation in high-risk patients (COPD, cardiac failure)

• CPAP: Constant positive pressure throughout respiratory cycle; best for cardiogenic pulmonary edema, OSA
• BiPAP (IPAP/EPAP): Separate inspiratory and expiratory pressures; best for COPD and neuromuscular failure
  • Typical starting: IPAP 10-12 cmH2O, EPAP 4-5 cmH2O, titrate to response
  • Target: RR decrease, SpO2 improvement, pH correction, relief of accessory muscle use

• Respiratory or cardiac arrest
• Uncooperative, agitated patient
• Unable to protect airway (swallowing, cough impairment)
• Excessive secretions not manageable
• Recent upper GI surgery or facial trauma

Step 5: Endotracheal Intubation and Invasive Mechanical Ventilation

• Failure or contraindication of NIV/HFNC
• GCS ≤8 or inability to protect airway
• Refractory hypoxemia (PaO2/FiO2 <100 despite maximal non-invasive support)
• Severe respiratory acidosis (pH <7.20)
• Hemodynamic instability / impending respiratory arrest
• Massive secretions or upper airway hemorrhage
• Post-cardiac arrest

ARDS (Berlin Criteria: PaO2/FiO2 <300 with bilateral infiltrates, not fully explained by cardiac failure):

• Lung-protective ventilation: VT 6 mL/kg IBW, plateau pressure <30 cmH2O
• Higher PEEP strategy for moderate-severe ARDS (guided by PEEP/FiO2 tables)
• Prone positioning for 16 hours/day in severe ARDS (PaO2/FiO2 <150) - reduces mortality (PROSEVA trial)
• Neuromuscular blockade (cisatracurium 48h) for severe ARDS - controversial but used for ventilator dyssynchrony
• Inhaled nitric oxide (iNO) or inhaled prostacyclin as rescue for refractory hypoxemia
• Corticosteroids (methylprednisolone) - may be considered for non-resolving ARDS
• ECMO (venovenous VV-ECMO) as last resort for refractory ARDS when conventional therapy fails - see below

COPD Exacerbation:

• Permissive hypercapnia acceptable (pH >7.20)
• Prolonged expiratory time (low RR, short I-time, high flow rate)
• Avoid high PEEP (risk of dynamic hyperinflation)
• Set extrinsic PEEP at ~80% of measured auto-PEEP to reduce inspiratory triggering work
• Wean aggressively; daily spontaneous breathing trials (SBTs)

Asthma (Status Asthmaticus):

• Permissive hypercapnia (pH >7.20)
• Low RR (8-12/min), low minute ventilation to prevent air trapping
• High inspiratory flow to maximize expiratory time
• Monitor for pneumothorax

Opioid/CNS Depression:

• Naloxone 0.4 mg IV/IM/intranasal for opioid-induced respiratory failure (titrate to avoid precipitating acute withdrawal)
• Reversal agents for residual neuromuscular blockade (sugammadex for rocuronium/vecuronium; neostigmine + glycopyrrolate for older agents)
• Schwartz's Principles of Surgery

Step 6: ECMO (Extracorporeal Membrane Oxygenation)

• Sabiston Textbook of Surgery

---

6. Pharmacological Management

Bronchodilators (obstructive disease)

• Short-acting beta-2 agonists (SABA): Salbutamol (albuterol) 2.5-5 mg nebulized q20min x3, then PRN; or MDI with spacer
• Short-acting anticholinergics (SAMA): Ipratropium bromide 0.5 mg nebulized q6h; additive to SABA
• IV magnesium sulfate: 1.2-2 g IV over 20 min in severe acute asthma - bronchodilator effect via Ca2+ antagonism
• IV methylxanthines (aminophylline): Second-line in severe refractory bronchospasm

Corticosteroids

• Systemic steroids in COPD exacerbations: Prednisolone 40 mg PO or methylprednisolone 0.5 mg/kg IV q6h x 5 days; reduce treatment failure and shorten hospitalization
• Dexamethasone for croup and post-extubation stridor

Diuretics

• For acute cardiogenic pulmonary edema: Furosemide 40-80 mg IV (or 2.5x home dose); reduces preload and relieves pulmonary congestion
• Combined with nitrates in acute pulmonary edema (IV nitrates reduce preload rapidly)

Antibiotics

• Indicated for infectious causes (pneumonia, COPD exacerbation with purulent sputum, sepsis-related RF)
• Target empirically based on suspected pathogen and severity; adjust per culture results

Opioids (palliative dyspnea management)

• Low-dose IV/SC morphine 2-4 mg PRN relieves distressing dyspnea in end-stage disease without significantly worsening respiratory status in carefully selected patients

Sedation and Analgesia (in mechanically ventilated patients)

• Analgesia-first approach: IV fentanyl or morphine for pain
• Light sedation target (RASS -1 to 0): Associated with better outcomes than deep sedation
• Propofol (ICU sedation, short-acting, easily titratable) or dexmedetomidine (alpha-2 agonist, preserves respiratory drive)
• Benzodiazepines (midazolam, lorazepam): Avoid in delirium; associated with worse ICU outcomes
• In ECMO patients, specific sedation goals are used to minimize circuit-drug interactions and facilitate earlier mobilization - Sabiston Textbook of Surgery

---

7. Supportive ICU Care

---

8. Weaning from Mechanical Ventilation

• Underlying cause resolving
• Hemodynamically stable (minimal or no vasopressors)
• Adequate oxygenation: SpO2 ≥92% on FiO2 ≤0.4, PEEP ≤8 cmH2O
• Capable of spontaneous respiratory effort
• Alert, following commands; intact cough/gag

• T-piece or pressure support (PS 5 cmH2O + PEEP 5 cmH2O) for 30-120 minutes
• Failed SBT signs: RR >35/min, SpO2 <90%, HR >140, BP swing >20%, agitation, diaphoresis

• Preferentially use HFNC or NIV BiPAP post-extubation in high-risk patients (COPD, cardiac failure, high APACHE score)
• High-flow nasal cannula is increasingly used for post-extubation respiratory failure in postoperative patients, with several studies demonstrating benefit - Schwartz's Principles of Surgery

---

9. Special Situations

Flail Chest

Neuromuscular Disease

• When respiratory failure is the end of progressive chronic insufficiency (e.g., advanced CF, ALS), mechanical ventilation may be unhelpful and goals-of-care discussions are required. For acute-on-chronic (e.g., viral pneumonia in CF), mechanical ventilation is appropriate in patients with previously good baseline pulmonary function. - Fishman's Pulmonary Diseases and Disorders

Postoperative Respiratory Failure

• Reverse residual neuromuscular blockade and opioid-induced respiratory depression
• HFNC or NIV as first-line; intubate if failing or contraindicated

---

10. Complications of Mechanical Ventilation

---

11. Key Prognostic Indicators

• PaO2/FiO2 ratio: <200 = moderate ARDS; <100 = severe ARDS; predicts mortality
• Driving pressure (plateau - PEEP): independent predictor of mortality in ARDS
• pH on admission: pH <7.20 associated with poor outcomes
• Duration of mechanical ventilation: >10-14 days significantly increases morbidity
• Patients who survive but remain "chronically critically ill" - require dedicated post-ICU rehabilitation programs

---

• Fishman's Pulmonary Diseases and Disorders, 5th ed., Chapter 139 (Respiratory Failure - Classification, Pathophysiology, Management)
• Murray & Nadel's Textbook of Respiratory Medicine, 7th ed., Chapter on HFNC and Acute Hypoxemic Respiratory Failure
• Rosen's Emergency Medicine, 9th ed., Chapter 60 (COPD and Respiratory Failure Classification)
• Sabiston Textbook of Surgery, Chapter 116 (ECMO in Respiratory and Cardiac Failure)
• Schwartz's Principles of Surgery, 11th ed., Chapter on Postoperative Respiratory Failure